Global Atovaquone and Proguanil Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Atovaquone and Proguanil Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum.
Atovaquone and Proguanil report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Atovaquone and Proguanil market is projected to reach US$ 191.2 million in 2029, increasing from US$ 129 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Adult and Paediatric are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Atovaquone and Proguanil industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Atovaquone and Proguanil key manufacturers include GSK, Glenmark, Mylan Pharmaceuticals and Hetero, etc. GSK, Glenmark, Mylan Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Atovaquone and Proguanil can be divided into 250 mg/100 mg and 62.5mg/25mg, etc. 250 mg/100 mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Atovaquone and Proguanil is widely used in various fields, such as Adult and Paediatric, etc. Adult provides greatest supports to the Atovaquone and Proguanil industry development. In 2022, global % sales of Atovaquone and Proguanil went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Atovaquone and Proguanil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Segment by Type
250 mg/100 mg
62.5mg/25mg
Adult
Paediatric
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Atovaquone and Proguanil market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Atovaquone and Proguanil, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Atovaquone and Proguanil industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Atovaquone and Proguanil in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Atovaquone and Proguanil introduction, etc. Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Atovaquone and Proguanil market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Atovaquone and Proguanil report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Atovaquone and Proguanil market is projected to reach US$ 191.2 million in 2029, increasing from US$ 129 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Adult and Paediatric are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Atovaquone and Proguanil industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Atovaquone and Proguanil key manufacturers include GSK, Glenmark, Mylan Pharmaceuticals and Hetero, etc. GSK, Glenmark, Mylan Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Atovaquone and Proguanil can be divided into 250 mg/100 mg and 62.5mg/25mg, etc. 250 mg/100 mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Atovaquone and Proguanil is widely used in various fields, such as Adult and Paediatric, etc. Adult provides greatest supports to the Atovaquone and Proguanil industry development. In 2022, global % sales of Atovaquone and Proguanil went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Atovaquone and Proguanil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Segment by Type
250 mg/100 mg
62.5mg/25mg
Segment by Application
Adult
Paediatric
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Atovaquone and Proguanil market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Atovaquone and Proguanil, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Atovaquone and Proguanil industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Atovaquone and Proguanil in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Atovaquone and Proguanil introduction, etc. Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Atovaquone and Proguanil market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices